PF-Atlas › Clinical Trials › NCT03761082

Post Marketing Surveillance of PIRESPA® TAB 200mg for Evaluating the Safety and Efficacy

NA · Not specified

Registry ID

NCT03761082

Phase

Not specified

Status

Completed

Drug / intervention

NA(observation study)

Sponsor

IlDong Pharmaceutical Co Ltd

Start

2014-07

Enrollment

258

About this trial

Post-marketing surveillance of Pirfenidone

View NCT03761082 on ClinicalTrials.gov →

Explore related

All NA trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT03761082 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.